Cannata’s Hosts ‘King Cakes for a Cause’ to Support Mary Bird Perkins Cancer Center at TGMC
Cannata’s Family Market is hosting its annual “King Cakes for a Cause” to support the local fight against cancer this Mardi Gras season with Mary Bird Perkins Cancer Center at TGMC.
Cannata’s will donate 10 percent of in-store Gooey Butter Snickerdoodle King Cake sales this Mardi Gras Season when shoppers mention Mary Bird Perkins at the register or when they order Gooey Butter Snickerdoodle through the bakery. Orders placed online www.cannataskingcakes.com when customers use the promo code “MARYBIRD” will also benefit the Cancer Center and can be shipped to friends, family members and businesses.
“We are grateful to have the partnership of Cannata’s Family Markets in the fight against cancer. King Cakes are a traditional treat that everyone enjoys and purchasing one in support of our Cancer Center is a great way to get involved in our community,” said Melanie Guilbeaux, Cancer Center Director.
All proceeds raised through “King Cakes for a Cause” will stay in the Bayou Region to help provide free cancer screenings, education and other patient care needs such as transportation assistance, nutritional supplements and medication assistance.
For more information about “King Cakes for a Cause” or about how you can support Mary Bird Perkins Cancer Center at TGMC, please contact Amy Ponson at (985) 851-8661 or email@example.com.
Mary Bird Perkins Cancer Center at TGMC provides the full spectrum of cancer care, from prevention and early detection to diagnosis, treatment, recovery and survivorship for those in the Bayou Region. Its services include chemotherapy, radiation therapy and surgery, as well as patient navigation, clinical trials and free community screenings. The Cancer Center is nationally accredited with commendation and recognized for excellence in cancer care by the American College of Surgeons Commission on Cancer as well as the national Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the prestigious American Society of Clinical Oncology (ASCO).